American Society of Hematology--44th Annual Meeting and Exposition. Drug highlights I. 6-10 December 2002, Philadelphia, PA, USA.
Adekale
Melanie
M
Thomson Current Drugs, Middlesex House, 34-42 Cleveland Street, London W1T 4LB, UK. melanie.adekale@current-drugs.com
D000818:Animals; D000906:Antibodies / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D003546:Cysteine Endopeptidases; D015316:Genetic Therapy; D006402:Hematologic Diseases / Q000188:drug therapy / Q000628:therapy*; D056572:Histone Deacetylase Inhibitors; D006801:Humans; D009097:Multienzyme Complexes / Q000037:antagonists & inhibitors; D010793:Phthalazines / Q000627:therapeutic use; D011108:Polymers / Q000627:therapeutic use; D011134:Polysaccharides / Q000627:therapeutic use; D046988:Proteasome Endopeptidase Complex; D011506:Proteins / Q000627:therapeutic use; D011725:Pyridines; D011994:Recombinant Proteins
D000906:Antibodies; D000970:Antineoplastic Agents; D056572:Histone Deacetylase Inhibitors; D009097:Multienzyme Complexes; D010793:Phthalazines; D011108:Polymers; D011134:Polysaccharides; D011506:Proteins; D011725:Pyridines; D011994:Recombinant Proteins; C464792:SanOrg 123781; C472014:synthetic erythropoiesis protein; C404768:vatalanib; D003546:Cysteine Endopeptidases; D046988:Proteasome Endopeptidase Complex